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Apoptosis of intestinal epithelial cells restricts
Clostridium difﬁcile infection in a model of
pseudomembranous colitis
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Clostridium difﬁcile is the leading cause of pseudomembranous colitis in hospitalized patients.
C. difﬁcile enterotoxins TcdA and TcdB promote this inﬂammatory condition via a cytotoxic
response on intestinal epithelial cells (IECs), but the underlying mechanisms are incompletely
understood. Additionally, TcdA and TcdB engage the Pyrin inﬂammasome in macrophages,
but whether Pyrin modulates CDI pathophysiology is unknown. Here we show that the Pyrin
inﬂammasome is not functional in IECs and that Pyrin signaling is dispensable for CDI-
associated IEC death and for in vivo pathogenesis. Instead, our studies establish that C.
difﬁcile enterotoxins induce activation of executioner caspases 3/7 via the intrinsic apoptosis
pathway, and demonstrate that caspase-3/7-mediated IEC apoptosis is critical for in vivo
host defense during early stages of CDI. In conclusion, our ﬁndings dismiss a critical role for
inﬂammasomes in CDI pathogenesis, and identify IEC apoptosis as a host defense
mechanism that restricts C. difﬁcile infection in vivo.
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Clostridium difﬁcile is a Gram-positive, toxin-producingand spore-forming obligatory anaerobic bacterial patho-gen. It most commonly infects patients that are on anti-
biotics treatment, which licenses C. difﬁcile outgrowth and
intestinal colonization by disrupting the gut microbiota1. C. dif-
ﬁcile infection (CDI) is thought to account for 15–30% of patients
suffering from antibiotic-associated diarrhea, and 3–8% of
patients with CDI progress to fulminant infection, a potentially
life-threatening inﬂammatory condition that may involve severe
ileus, toxic megacolon, colonic perforation with subsequent
peritonitis, and septic shock. The pathophysiology of CDI is
strictly associated with the production of TcdA and TcdB, two
major pathogenic enterotoxins with cytotoxic properties that
drive the hallmark symptoms of pseudomembranous colitis2,3.
TcdA and TcdB both are exotoxins that primarily target intestinal
epithelial cells (IECs) in the intestinal tract. Once internalized via
endocytic mechanisms, they autoprocess in the acidiﬁed endo-
some, and the amino-terminal cleavage fragments gain access to
the cytosol4. TcdA and TcdB both are glucosyltransferases that
selectively monoglucosylate a conserved threonine residue that is
critical for GTP binding by members of the Rho, Rac and
Cdc42 small GTPase families5,6. TcdA/B-mediated mono-
glucosylation results in Rho GTPase inactivation, disruption of
the cytoskeleton dynamics, cell rounding and intestinal epithelial
cell cytotoxicity, and intestinal damage and permeabilization,
consequently leading to bowel inﬂammation and life-threatening
diarrhea1.
Recent reports showed that TcdA/B-mediated inactivation of
RhoA GTPases in mouse macrophages and human peripheral
blood mononuclear cells (PBMCs) engages the Pyrin inﬂamma-
some7–10. Inﬂammasomes comprise a set of large multiprotein
complexes that recruit and promote cleavage and activation of the
cysteine protease caspase-1. Once active, caspase-1 drives pro-
cessing of the pro-inﬂammatory cytokines interleukin (IL)-1β and
IL-18 into their active forms11. In addition, caspase-1 cleaves
gasdermin D (GSDMD), the amino-terminal fragment of which
inserts in the plasma membrane to induce a lytic cell death mode
termed pyroptosis12–16. Other intracellular pattern recognition
receptors (PRRs) that engage an inﬂammasome response include
the nucleotide-binding oligomerization domain, leucine rich
repeat containing (NLR) family members NLRP1, NLRP3 and
NLRC4; and the HIN200 family member AIM217. Although
inﬂammasome activation has been extensively documented to
mediate protective as well as detrimental responses during bac-
terial, viral and fungal infections18, the physiological role of
inﬂammasome activation in the context of CDI is unknown.
Moreover, the molecular mechanisms and pathophysiological
roles of C. difﬁcile-induced IEC cytotoxicity are unclear. Previous
studies that primarily relied on the use of pharmacological agents
in immortalized IEC cell lines variably proposed that TcdA and
TcdB may induce IEC cytotoxicity via caspase-dependent or
-independent mechanisms19–26.
Here we took advantage of state-of-the-art ex vivo models of C.
difﬁcile-infected and TcdA/B-intoxicated primary IEC organoid
cultures to deﬁne the mechanisms of C. difﬁcile-induced
IEC cytotoxicity. Additionally, we explored the pathophysiologi-
cal role of IEC killing in mice challenged in vivo with live C.
difﬁcile. We found that unlike in myeloid cells, the Pyrin
inﬂammasome is not functional in IECs and that the central
pyroptosis effector GSDMD is dispensable for C. difﬁcile toxin-
induced IEC killing. We further established that genetic inacti-
vation of the necroptosis effector MLKL nor the apoptotic
initiator caspase-8 altered the course of TcdA/B-induced IEC
killing. Instead, we identiﬁed C. difﬁcile toxin-induced activation
of the apoptotic executioner proteases caspases 3 and 7 by the
intrinsic apoptosis pathway as a critical mechanism driving IEC
death. Finally, we established that the Pyrin inﬂammasome is
dispensable in vivo for host defense against CDI, whereas selec-
tive deletion of caspases 3 and 7 in IECs exacerbated bacterial
burdens and clinical parameters of CDI during early stages of
infection.
Results
Inﬂammasomes are dispensable for toxin-induced IEC cyto-
toxicity. Intoxication of both mouse macrophages and human
PBMCs with either TcdA or TcdB was recently shown to engage
the Pyrin inﬂammasome, which induces pyroptosis and release of
the matured inﬂammatory cytokines IL-1β and IL-187–10. How-
ever, these toxins primarily target IECs in the context of CDI, but
whether the Pyrin inﬂammasome drives toxin-induced IEC death
and plays a pathophysiological role during CDI is not known. To
explore effector mechanisms that promote IEC cytotoxicity, cell
death induction in primary IEC organoids was monitored by
time-lapse imaging following intoxication with TcdA and TcdB.
Wild-type intestinal organoids displayed a shrinking and dis-
organized cellular architecture that was associated with incor-
poration of the cell-impermeant DNA-intercalating agent
propidium iodide (PI) already during initial hours of intoxication,
and appeared dead by 16 h post-treatment (Fig. 1a). Similarly,
intestinal organoids from Mefv−/− mice (lacking expression of
the inﬂammasome sensor Pyrin) incorporated PI and displayed
cell death features with kinetics resembling that of wild-type IEC
organoids (Fig. 1a), indicating that Pyrin signaling is dispensable
for TcdA-induced cytotoxicity of IECs. We next intoxicated
intestinal organoids from Asc−/−, C1−/−C11−/− and Gsdmd−/−
mice to verify whether TcdA-induced IEC death was routed
through inﬂammasomes other than the Pyrin pathway. Notably,
IECs lacking the core inﬂammasome components ASC, caspase-
1/11 or GSDMD all were equally sensitive to TcdA-induced
cytotoxicity and died with kinetics resembling that of wild-type
IEC organoids (Fig. 1b–d). Importantly, TcdB-induced IEC
cytotoxicity was unaltered in intestinal organoids from Mefv−/−
mice (Supplementary Fig. 1). IEC death was toxin-induced
because mock-treated organoids of all analyzed genotypes failed
to undergo cell death during the observed timeframe (Supple-
mentary Fig. 2A-D). Together, these results demonstrate that
unlike in monocytes and macrophages, Pyrin inﬂammasome
activation and inﬂammasome-induced pyroptosis are dispensable
for IEC cytotoxicity induced by C. difﬁcile toxins TcdA and TcdB.
To clarify why TcdA and TcdB failed to induce Pyrin-
dependent pyroptosis in IECs, we analyzed the transcript levels of
Mefv (that encode Pyrin) in a public gene expression proﬁle
dataset from BioGPS27 (Fig. 2a) and by tissue real-time qPCR
analysis (Fig. 2b). Consistent with a recent report demonstrating
that Mefv expression in the intestinal tract is conﬁned to lamina
propria cells and absent from the IEC fraction28, we detected high
Mefv transcript levels in bone marrow and myeloid cells
(macrophages, monocytes, dendritic cells and neutrophils)
whereas adrenal gland, bladder, heart, kidney, thymus, liver,
lung and small and large intestines were virtually devoid of Mefv
expression (Fig. 2a, b). Consistent with the low transcript levels in
intestinal IECs (Fig. 2a), we also could not detect Pyrin expression
at the protein level in cell lysates of intestinal organoids grown
in vitro (Fig. 2c). As expected, robust Pyrin expression was
detected in BMDM cell lysates (Fig. 2c). Together, these results
suggest that Pyrin inﬂammasome signaling is restricted to cells of
the myeloid lineage, contrary to the NLRC4 and NLRP3
inﬂammasomes that are functional in both myeloid cells and
IECs29–32. In agreement, TcdA, TcdB and FlaTox (a biochemical
ligand of the NAIP5/NLRC4 inﬂammasome29,33) all triggered
IEC death in primary organoids (Fig. 2d and Supplementary
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Fig. 1 Inﬂammasome activation and pyroptosis are dispensable for C. difﬁcile TcdA-induced IEC cytotoxicity. a–d Primary intestinal organoids from wild-
type (WT) and aMefv−/−, b Asc−/−, c Casp1/11−/− or d Gsdmd−/−mice were stimulated with TcdA and PI incorporation analyzed by live-imaging for 16 h.
Graphs correspond to PI quantiﬁcation plotted by organoid area. Scale bars: 30 µm. The data are representative of at least 3 independent experiments
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07386-5 ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:4846 | DOI: 10.1038/s41467-018-07386-5 | www.nature.com/naturecommunications 3
Movie 1), but only FlaTox-induced cytotoxicity was associated
with release of the inﬂammasome-dependent cytokine IL-18
(Fig. 2e). Moreover, the morphological changes of IECs under-
going TcdA/TcdB-induced cell death differed dramatically from
FlaTox-stimulated IECs undergoing pyroptosis (Supplementary
Movie 1), adding further credence to the notion that TcdA/TcdB-
induced cytotoxicity differs from pyroptosis. In conclusion, these
results demonstrate that Pyrin expression and Pyrin inﬂamma-
some signaling likely are restricted to the myeloid compartment,
and that C. difﬁcile toxins trigger a cell death mode in IECs that
differs from inﬂammasome-induced pyroptosis.
Caspases 3 and 7 drive C. difﬁcile-induced IEC death. Having
ruled out pyroptosis induction as the mechanism of TcdA/B-
induced IEC killing and based on our previous ﬁndings (Figs 1
and 2), we next asked whether C. difﬁcile toxins elicited an
apoptotic response in intoxicated IEC organoids. To this end,
lysates of wild-type intestinal organoids that had been challenged
with TcdA and TcdB, respectively, were examined by immuno-
blotting for activation of the apoptotic executioner caspases 3 and
7 (Fig. 3a). We observed robust cleavage of both caspases that was
comparable to caspase-3/7 activation levels that were elicited by
staurosporine, a broad-spectrum kinase inhibitor and a potent
pro-apoptotic chemotherapeutic agent (Fig. 3a). Given these
results, we next infected IEC organoids with either a toxicogenic
wild-type strain of C. difﬁcile or a mutant strain lacking expres-
sion of both TcdA and TcdB. Notably, wild-type C. difﬁcile
infection elicited robust activation of caspases 3 and 7, a response
that was blunted in IEC organoids that had been infected with the
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Fig. 2 Pyrin is not expressed in IECs. a Public microarray dataset of Mefv expression proﬁle across different cell types and tissues. Expression values relate
to ﬂuorescence intensity from Affymetrix chips. b Real time qPCR of Mefv expression in different tissues and cell types. c Cell lysates from primary
intestinal organoids of wild-type and Mefv-−/− mice were prepared and immunoblotted for total Pyrin and β-actin. d Primary intestinal organoids wild-type
mice were stimulated with TcdA, TcdB or FlaTox and PI incorporation analyzed by live-imaging for 16 h. e Primary intestinal organoids wild-type mice were
stimulated with TcdA, TcdB or FlaTox for 16 h and culture supernatant was analyzed for IL-18 secretion. Scale bars: 30 µm. Data are representative of 3
independent experiments
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toxin-deﬁcient mutant strain (Fig. 3b), in agreement with the
established requirement for TcdA/TcdB in C. difﬁcile-induced
cytotoxicity. Moreover, PARP1 cleavage - a hallmark feature of
apoptosis - was readily detected in intestinal organoids that had
been intoxicated with TcdA or TcdB (Fig. 3a) or infected with
toxigenic C. difﬁcile (Fig. 3b), further demonstrating activation of
executioner caspases 3 and 7 in these conditions.
To functionally validate the role of caspases 3 and 7 in TcdA/B-
induced IEC killing, we produced intestinal organoids from mice
with a combined IEC-speciﬁc deletion of these executioner
caspases (Casp3/7IEC-KO) by breeding mice with conditionally
targeted Casp3 and Casp7 alleles (Casp3/7 F/F) to animals
expressing Cre recombinase under control of the IEC-speciﬁc
Villin promoter (Villin-Cre). Western blot analysis for caspases 3
and 7 showed expression of both executioner caspases in wild-
type IECs and conﬁrmed their efﬁcient deletion in Casp3/7IEC-KO
organoids (Fig. 3c). Notably, TcdA and TcdB-induced IEC
cytotoxicity was abolished in Casp3/7IEC-KO organoids, which was
further supported by a failure to incorporate PI during the
studied timeframe (Fig. 3d, e). In marked contrast, TcdA/TcdB-
intoxication of control Casp3/7F/F organoids resulted in a swift
cell death response within the initial hours of intoxication
(Fig. 3d). As expected, mock-treated IEC organoids failed to
undergo cell death during the observed timeframe (Supplemen-
tary Fig. 3), conﬁrming speciﬁcity of these ﬁndings. Collectively,
these results establish that apoptotic executioner caspases 3 and 7
are critical for C. difﬁcile-induced IEC cytotoxicity.
Bax/Bak pores contribute to TcdA/TcdB-induced IEC killing.
Given that our studies in Casp3/7IEC-KO organoids established a
role for apoptotic executioner caspases in C. difﬁcile toxin-
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induced IEC death, we next sought to analyze the upstream
mechanisms promoting activation of caspases 3 and 7. Initiation
of classical apoptosis is mediated by two distinct pathways; an
intrinsic (mitochondrial) and extrinsic (death receptor) path-
way34. RIPK1 is a kinase that modulates a regulated necrotic cell
death mode termed necroptosis as well as apoptosis induction
under certain conditions35. However, intestinal organoids from
mutant mice that lack RIPK1 kinase activity (R1 KD mice) were
killed by TcdA stimulation with similar efﬁciency as wild-type
IECs (Fig. 4a). Moreover, absence of RIPK3—a related kinase that
is essential for induction of necroptosis—failed to protect
intestinal organoids against TcdA and TcdB-induced intoxica-
tion, regardless whether it was deleted alone or in combination
with the apical initiator caspase-8 that drives death receptor-
induced apoptosis (Fig. 4b and Supplementary Fig. 4A). Notably,
transgenic expression of anti-apoptotic Bcl-2 under control of the
LPK promoter for expression in IECs and hepatocytes, supported
a slight but reproducible protection against TcdA/TcdB-induced
cell death (Fig. 4c, Supplementary Fig. 5A and Supplementary
Fig. 6). Intestinal organoid cell death was toxin-induced as
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evidenced by the lack of cytotoxicity in mock-treated controls of
all analyzed genotypes (Supplementary Fig. 7A–C). These results
suggest that RIP kinases and death receptor-induced apoptosis
are dispensable, whereas mitochondrial Bax/Bak pores partially
contribute to TcdA/TcdB-induced caspase-3/7 activation and
IEC apoptosis. In agreement, TcdA and TcdB intoxication of
Ripk3−/− and Ripk3−/−Casp8−/− organoids failed to alter clea-
vage of caspases 3 and 7 (Fig. 4d and Supplementary Fig. 4B).
Although activation of caspases 3 and 7 was not substantially
altered in Bcl-2 transgenic IECs following TcdA intoxication
(Fig. 4e), it was mildly reduced after TcdB intoxication (Supple-
mentary Fig. 5B). In conclusion, these results exclude a role for
death receptor-induced apoptosis and necroptosis signaling in C.
difﬁcile toxin-induced IEC cytotoxicity, and suggest that
mechanisms redundant to the pro-apoptotic Bax/Bak pore that
lead to mitochondrial outer membrane permeabilization
(MOMP) may promote TcdA/B-induced caspase-3/7 activation
and IEC apoptosis through the intrinsic apoptosis pathway.
IEC apoptosis restricts C. difﬁcile growth in vivo. Having
established that C. difﬁcile-induced IEC death corresponds to
caspase-3/7-mediated apoptosis via the intrinsic pathway, we next
sought to investigate its pathophysiological role in an established
mouse model of live CDI36. In this in vivo infection model, lit-
termate mice of the indicated genotypes are treated with a
cocktail of antibiotics during 5 days prior to infection in order to
create a niche in the intestinal tract that supports C. difﬁcile
growth (Fig. 5a). Following infection, mice are assessed daily for a
number of clinical parameters during a period of 14 days and
stool samples are taken at regular intervals to assess bacterial
burden. Corroborating our ﬁndings that the Pyrin inﬂammasome
is not functional in IECs (Fig. 1), Mefv+/+ and Mefv−/− litter-
mate mice responded to C. difﬁcile infection with a comparable
decline in body weight over the course of infection (Fig. 5b).
Moreover, stool consistency - which is a robust surrogate marker
of CDI severity - was equally affected in infected Mefv+/+ and
Mefv−/− littermate mice (Fig. 5c). Consistently, longitudinal
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quantitative assessment of C. difﬁcile replication in stool samples
of infected mice conﬁrmed that systemic disruption of Pyrin
inﬂammasome activation failed to impact C. difﬁcile replication
rates during infection as evidenced by the similar bacterial loads
detected in the stool of Mefv+/+ and Mefv−/− littermate mice
(Fig. 5d).
In marked contrast to Pyrin-deﬁcient mice, selective deletion of
executioner caspases 3 and 7 in IECs caused Casp3/7IEC-KO mice
to lose signiﬁcantly more body weight during initial stages of
infection relative to littermate Casp3/7F/F mice that do express
these executioner caspases in IECs (Fig. 5e). Moreover, stool
scores of Casp3/7IEC-KO mice were signiﬁcantly elevated relative
to those of Casp3/7F/F control mice (Fig. 5f). We extended these
results by quantifying C. difﬁcile burdens in the stool. This
analysis showed that Casp3/7IEC-KO and littermate Casp3/7 F/F
mice had equal C. difﬁcile counts on the ﬁrst day of infection.
However, Casp3/7IEC-KO mice continued to present with high
infection rates by day 3 post-infection, contrary to Casp3/7 F/F
mice that started to clear the infection (Fig. 5g). Casp3/7IEC-KO
mice eventually controlled C. difﬁcile burdens and progressed
towards self-limiting disease as evidenced by the reduced bacterial
counts detected by day 7 post-infection (Fig. 5g). Collectivity,
these results demonstrate that the Pyrin inﬂammasome is
dispensable, whereas caspase-3/7-mediated IEC apoptosis is a
critical host defense mechanism that protects against C. difﬁcile
infection during early stages of CDI.
Discussion
CDI is a major public health concern. It is estimated that the
number of people infected with C. difﬁcile is higher than those
infected with Salmonella species in Europe and the United
States1. The high incidence of CDI is associated with the emer-
gence of hypervirulent C. difﬁcile strains in Europe and North
America in the new millennium, which was recently suggested to
be associated with the widespread adoption of trehalose as an
additive in human diets37. Therefore, molecular analysis of C.
difﬁcile-host interactions and better understanding of how this
bacterial pathogen instigates host pathology may improve disease
prevention and inform novel therapeutic approaches.
The immune response to C. difﬁcilemay be both protective and
detrimental to the host, depending on its magnitude. Neutrophil
recruitment into the intestinal tract consequent to NF-κB sig-
naling via the TLR4 and Nod1 signaling axes is essential for
protecting the host against C. difﬁcile, as evidenced by decreased
survival rates in mice lacking these PRRs38,39. Notably, a poly-
morphism in the human IL8 gene that results in increased pro-
duction of IL-8, a neutrophil chemoattractant, is associated with
increased risk for C. difﬁcile recurrence40,41, highlighting the
importance of a balanced immune response during infection.
TLR5 engagement has also been linked to protection against
CDI42. In addition, innate lymphoid cells (ILCs), mainly ILC1
and to a lesser extent ILC3, also contribute to protection against
acute CDI via the induction of IL-22 and IFN-γ43.
Although inﬂammasomes are central conduits of innate
immune responses, their role in CDI is incompletely understood.
TcdA and TcdB were recently shown to engage the Pyrin
inﬂammasome in mouse and human myeloid cells, leading to
secretion of IL-1β and IL-18 and induction of pyroptosis7–9.
However, IECs are the primary target cells of C. difﬁcile exotoxins
in the context of CDI pathophysiology. Previous studies suggested
both protective and detrimental roles for the inﬂammasome
adaptor ASC during CDI44,45, but whether Pyrin inﬂammasome
signaling impacts on C. difﬁcile-induced IEC cytotoxicity and
modulates the course of CDI pathophysiology in vivo is
unknown. Here, we showed in primary IEC organoid systems
that C. difﬁcile-induced IEC cytotoxicity is fully mediated by its
exotoxins, and that the Pyrin inﬂammasome (and inﬂammasome
activation in general) is dispensable for TcdA/TcdB-induced IEC
killing, which we linked to absent Pyrin expression and func-
tionality in IECs. This markedly contrasts to the situation in
myeloid cells, where Pyrin is highly expressed and inﬂammasome
activation elicits pyroptotic cell death in response to TcdA/TcdB-
induced RhoA modiﬁcation7–9, thus highlighting the cell type
speciﬁcity of host-pathogen interactions. Moreover, we provided
genetic evidence that TcdA and TcdB-induced IEC death criti-
cally relied on caspase-3/7-mediated apoptosis through the
intrinsic apoptotic pathway, whereas blockade of both caspase-8-
mediated death receptor-induced apoptosis and necroptotic sig-
naling failed to protect from TcdA/TcdB-induced IEC cytotoxi-
city. Notably, transgenic expression of the anti-apoptotic protein
Bcl-2 in intestinal organoids did not fully recapitulate the pro-
tective phenotype of IECs lacking caspases 3 and 7, suggesting
that mechanisms in addition to the Bax/Bak pore may promote
MOMP during CDI. Indeed, Bcl2-transgenic IECs continued to
engage caspases 3 and 7 in response to TcdA and TcdB. Thus,
although Bax/Bak-independent mitochondrial membrane per-
meabilization has been reported to induce release of cytochrome c
into the cytosol47–49, future work should address the mechanisms
by which C. difﬁcile toxins cause MOMP and caspase-3/7 acti-
vation. Moreover, a recent report showed that TcdA and TcdB
also induce cell death of human IEC organoids46, and future
studies should address whether the molecular cytotoxicity
mechanisms we have uncovered in the murine system are con-
served in humans.
Induction of cell death upon microbial infections is generally a
host defense mechanism50. Some pathogens have evolved virulence
mechanisms that manipulate cell death pathways in order to pro-
mote their replication and dissemination in a hostile host environ-
ment. For instance, poxviruses and several bacterial pathogens
encode effector proteins that interfere with activation of apoptotic
caspases and/or inﬂammasomes, thereby preventing host apoptosis
and pyroptosis, respectively51,52. However, it is currently unknown
whether IEC cytotoxicity in the context of CDI is detrimental or
beneﬁcial to the host. We found that mice lacking apoptotic
executioner caspases 3 and 7 selectively in IECs were signiﬁcantly
more susceptible to CDI compared to littermate control mice. In
agreement, we measured increased bacterial replication rates in the
stool of Casp3/7IEC-KO mice. Notably, Casp3/7IEC-KO mice restored
control of CDI infection with delayed kinetics, pointing to
apoptosis-independent anti-microbial mechanisms that support C.
difﬁcile clearance. Although it is tempting to speculate that in rare
cases of systemic C. difﬁcile toxin dissemination, activation of the
Pyrin inﬂammasome in myeloid cells might exert a detrimental role
to the host by promoting excessive myeloid cell pyroptosis and
inﬂammatory tissue damage, our results suggest that the Pyrin
inﬂammasome is dispensable for host defense during self-limiting
pseudomembranous colitis. Moreover, the lack of Pyrin expression
in IECs prevents this cell type to undergo pyroptosis following C.
difﬁcile toxin exposure, and instead promotes IEC apoptosis as the
dominant IEC death mode during CDI in vivo. These ﬁndings
suggest that C. difﬁcile-induced IEC apoptosis is an early host
defense mechanism that contributes to bacterial restriction and toxin
production, most likely by promoting clearance of infected cells in
the intestinal epithelium by professional phagocytes and inﬁltrating
neutrophils.
Methods
Mice. Mefv−/−8, Asc-−/−53, Casp1−/−Casp11−/−54, Gsdmd−/−14, Ripk3−/−55,
Ripk3−/−Casp8−/−55 and Ripk1D138N55 mice have been described. C57BL/6 ES cells
(JM8A3.N1) with conditionally targeted casp3 (clone HEPD0716_4_A08) and casp7
(clone EPD0398_5_C04) alleles were obtained from the European Conditional Mouse
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Mutagenesis (EUCOMM) program (http://www.mousephenotype.org/about-ikmc/
eucommtools) and Casp3/7 conditional mice (Casp3/7ﬂ/ﬂ) mice were generated at the
VIB Transgenic Mouse Core Facility. Casp3/7ﬂ/ﬂ were crossed with Villin-Cre mice to
generate mice with speciﬁc deletion of Caspase-3 and -7 in IECs. B6.Cg-Tg(Pklr-
BCL2)BAk/Orl mice overexpressing human Bcl-2 under the LPK promoter (LPK-Bcl-
2) were rederived from embryos and purchased from EMMA (EM:05819). Mice were
housed in individually ventilated cages and were maintained in speciﬁc pathogen-free
facilities of Ghent University. Animal studies were approved by the ethics
committees on laboratory animal welfare of Ghent University under permission
number EC2016-11.
Intestinal organoid culture and live imaging. Primary intestinal epithelial orga-
noids were grown as described before56. Brieﬂy, the small intestine and colon were
ﬂushed and cut into small pieces that were dissociated in PBS containing 2mM EDTA
for 30min at 4 °C. After extensive washing, the isolated crypts were pelleted and mixed
with 25 μl of Matrigel (Corning) and put in a 24-well plate. After polymerization of the
Matrigel, complete culture medium containing advanced DMEM/F12 (Gibco) sup-
plemented with B27 supplement (0.02%, Invitrogen), N2 supplement (0.1%, Invitro-
gen), N-acetylcysteine (0.0025%, Sigma-Aldrich), mouse epidermal growth factor
(mEGF; 0.001%, Invitrogen), and conditioned Rspondin and mNoggin medium was
added to the wells. Organoids were seeded and imaged in an 8-well chamber (iBidi) for
cell death analysis by real time lapse microscopy or in 24-well plates for Western
blotting analysis. Cell death was induced with TcdA (1 µg/ml, Enzo Life Sciences),
TcdB (1 µg/ml, List Laboratories), staurosporine (1 µM; SelleckChem), FlaTox
(anthrax PA (500 ng/ml, Quadratech) and 1 μg/ml LFn-FlaA57) or C. difﬁcile (1 × 106).
Live-cell imaging was performed on an Axio Observer Z1 (Zeiss) equipped with a
CSU-X1 spinning-disk head (Yokogawa) and AxioCam MRm (Zeiss), with a EC Plan-
Neoﬂuar 10 × dry objective (numerical aperture [NA] 0.30). Images were acquired
every 15min for 20 h. Data analysis and image reconstruction were performed with
ImageJ (NIH) by measuring PI intensity and organoid area. PI intensity was divided by
organoid area to obtain ﬁnal values.
Clostridium difﬁcile infection. Clostridium difﬁcile strains VPI10463 (toxigenic;
TcdA+TcdB+) and VPI11186 (nontoxigenic; TcdA-TcdB-) were purchased from
ATCC. Glycerol stocks were cultured overnight at 37 °C in anaerobic conditions in
BHIS enriched medium (37 g/l brain heart infusion—Gibco; 5 g/l yeast extract—
Gibco; 0.03% L-cysteine—Sigma; 0.1% sodium taurocholate—Sigma). For C. difﬁ-
cile in vivo infection, mice received antibiotics cocktail (2 mg/ml ampicillin, 0.4 mg/
ml kanamycin, 0.035 mg/ml gentamicin, 850 U/ml colistin, 0.215 mg/ml metro-
nidazole and 0.045 mg/ml vancomycin) in drinking water for 5 days followed by
2 days in normal drinking water. One day prior infection, mice were injected with a
single intraperitoneal injection of the broad-spectrum antibiotic clindamycin (10
mg/kg). On the day of infection, mice were infected with 106 vegetative cells of C.
difﬁcile through oral gavage. Mice were checked daily for body weight change and
stool consistency. Stool samples were collected on days 0, 1, 3, 7 and 14 post-
infection for CFU quantiﬁcation.
Stool DNA extraction and C. difﬁcile quantiﬁcation. Fecal samples from mice on
days 0, 1, 3, 7 and 14 post-infection were collected into sterile soil grinding SK28
tubes (432-0140, Bertin Technologies). Stool samples were processed for gDNA
extraction using the QIAamp Fast DNA Stool Mini Kit (51604, Qiagen) according
to the manufacturer’s instructions. Brieﬂy, stool samples were homogenized in
InhibitEX buffer by bead-beating using the Precellys®24 (Bertin Technologies).
Fecal homogenates were incubated with proteinase K followed by ethanol pre-
cipitation. Stool DNA was diluted in ultrapure sterile water. Quantiﬁcation of C.
difﬁcile in stool samples was performed by quantitative PCR (qPCR) as previously
described58. Brieﬂy, qPCR was performed in 30 ng stool DNA samples using
LightCycler 480 SYBR Green I Master Mix kit (4707516001, Roche) in a Light-
Cycler 480 real-time PCR machine (Roche). The standard curve was prepared by
isolating C. difﬁcile DNA and preparing serial dilutions. Primers used to identify
the tcdB gene were 5′-GAAGGTGGTTCAGGTCATAC-3′ and 5′-CATTTTC-
TAAGCTTCTTAAACCTG-3′.
Gene expression analysis. Mefv expression across several tissues and cell types
were obtained from the BioGPS public database (http://ds.biogps.org/?
dataset=GSE10246&gene=54483) and plotted accordingly. For tissue qPCR,
selected tissues were collected from wild-type mice and total RNA was extracted
with using the RNeasy kit (74104, Qiagen). RNA (1 μg) was used for cDNA
synthesis with iScript reagents (1725037, Bio-Rad). Samples were normalized to the
housekeeping gene Gapdh. Primers used were murine Gapdh, 5′-
GGTGAAGGTCGGTGTGAACG-3′ and 5′-CTCGCTCCTGGAAGATGGTG-3′;
murine Mefv, 5′-TCATCTGCTAAACACCCTGGA-3′ and 5′-GGGATCTTAG
AGTGGCCCTTC-3′.
Western blotting. Organoids in matrigel were mechanically disrupted and
samples were denatured in Laemmli buffer, boiled at 95 °C for 10min, separated by
SDS-PAGE and transferred to nitrocellulose membranes. PBS supplemented with
0.05% Tween-20 (v/v) and 3% nonfat dry milk (w/v) was used for blocking and
washing of membranes. Immunoblots were incubated overnight with
primary antibodies against full-length and cleaved caspase-3 (9662 S and 9664 S,
1:1000, Cell Signaling), full-length and cleaved caspase-7 (9492 S and 9491 S, 1:1000,
Cell Signaling), PARP (9532 S, 1:1000, Cell Signaling), Pyrin (ab195975, 1:1000,
Abcam) or tubulin (ab6046, 1:2000, Abcam), followed by HRP-conjugated secondary
antibody raised against rabbit (111-035-144, 1:5000, Jackson ImmunoResearch
Laboratories). For some loading controls, β-Actin-HRP (sc-47778 HRP, 1:10,000,
Santa Cruz) antibody was used. All proteins were detected by enhanced chemilu-
minescence (Thermo Scientiﬁc). Western blot uncropped scans are available in the
Supplementary Information.
Cytokine analysis. IL-18 levels in cell culture medium were determined by
magnetic bead-based multiplex assay using Luminex technology (Bio-Rad)
according to the manufacturer’s instructions.
Statistical analysis. Statistical analysis was performed using GraphPad Prism
7.0 software. Data are shown as mean ± SD. The data were compared with the
nonparametric Mann–Whitney U test for in vivo studies and two-way ANOVA for
in vitro studies. P < 0.05 was considered statistically signiﬁcant; *P < 0.05, **P <
0.01, and ***P < 0.001.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this paper.
Data availability
The data that support the ﬁndings of this study are available from the corre-
sponding author upon request. A reporting summary for this article is available as a
Supplementary Information ﬁle.
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